230 related articles for article (PubMed ID: 28119481)
1. Lacosamide Inhibition of Nav1.7 Voltage-Gated Sodium Channels: Slow Binding to Fast-Inactivated States.
Jo S; Bean BP
Mol Pharmacol; 2017 Apr; 91(4):277-286. PubMed ID: 28119481
[TBL] [Abstract][Full Text] [Related]
2. The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels.
Errington AC; Stöhr T; Heers C; Lees G
Mol Pharmacol; 2008 Jan; 73(1):157-69. PubMed ID: 17940193
[TBL] [Abstract][Full Text] [Related]
3. Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: a comparison with carbamazepine, oxcarbazepine and lacosamide.
Hebeisen S; Pires N; Loureiro AI; Bonifácio MJ; Palma N; Whyment A; Spanswick D; Soares-da-Silva P
Neuropharmacology; 2015 Feb; 89():122-35. PubMed ID: 25242737
[TBL] [Abstract][Full Text] [Related]
4. Differential block of sensory neuronal voltage-gated sodium channels by lacosamide [(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide], lidocaine, and carbamazepine.
Sheets PL; Heers C; Stoehr T; Cummins TR
J Pharmacol Exp Ther; 2008 Jul; 326(1):89-99. PubMed ID: 18378801
[TBL] [Abstract][Full Text] [Related]
5. The Selective Nav1.7 Inhibitor, PF-05089771, Interacts Equivalently with Fast and Slow Inactivated Nav1.7 Channels.
Theile JW; Fuller MD; Chapman ML
Mol Pharmacol; 2016 Nov; 90(5):540-548. PubMed ID: 27587537
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of lacosamide and classical sodium channel blocking antiepileptic drugs on sodium channel slow inactivation.
Niespodziany I; Leclère N; Vandenplas C; Foerch P; Wolff C
J Neurosci Res; 2013 Mar; 91(3):436-43. PubMed ID: 23239147
[TBL] [Abstract][Full Text] [Related]
7. Block of human cardiac sodium channels by lacosamide: evidence for slow drug binding along the activation pathway.
Wang GK; Wang SY
Mol Pharmacol; 2014 May; 85(5):692-702. PubMed ID: 24563546
[TBL] [Abstract][Full Text] [Related]
8. Lacosamide: a new approach to target voltage-gated sodium currents in epileptic disorders.
Curia G; Biagini G; Perucca E; Avoli M
CNS Drugs; 2009; 23(7):555-68. PubMed ID: 19552484
[TBL] [Abstract][Full Text] [Related]
9. State-dependent trapping of flecainide in the cardiac sodium channel.
Ramos E; O'leary ME
J Physiol; 2004 Oct; 560(Pt 1):37-49. PubMed ID: 15272045
[TBL] [Abstract][Full Text] [Related]
10. Lidocaine Binding Enhances Inhibition of Nav1.7 Channels by the Sulfonamide PF-05089771.
Jo S; Bean BP
Mol Pharmacol; 2020 Jun; 97(6):377-383. PubMed ID: 32193331
[TBL] [Abstract][Full Text] [Related]
11. Ranolazine reduces neuronal excitability by interacting with inactivated states of brain sodium channels.
Kahlig KM; Hirakawa R; Liu L; George AL; Belardinelli L; Rajamani S
Mol Pharmacol; 2014 Jan; 85(1):162-74. PubMed ID: 24202911
[TBL] [Abstract][Full Text] [Related]
12. Functional consequences of lidocaine binding to slow-inactivated sodium channels.
Balser JR; Nuss HB; Romashko DN; Marban E; Tomaselli GF
J Gen Physiol; 1996 May; 107(5):643-58. PubMed ID: 8740377
[TBL] [Abstract][Full Text] [Related]
13. Current understanding of the mechanism of action of the antiepileptic drug lacosamide.
Rogawski MA; Tofighy A; White HS; Matagne A; Wolff C
Epilepsy Res; 2015 Feb; 110():189-205. PubMed ID: 25616473
[TBL] [Abstract][Full Text] [Related]
14. Cannabidiol Inhibition of Murine Primary Nociceptors: Tight Binding to Slow Inactivated States of Na
Zhang HB; Bean BP
J Neurosci; 2021 Jul; 41(30):6371-6387. PubMed ID: 34131037
[TBL] [Abstract][Full Text] [Related]
15. A Nav1.7 channel mutation associated with hereditary erythromelalgia contributes to neuronal hyperexcitability and displays reduced lidocaine sensitivity.
Sheets PL; Jackson JO; Waxman SG; Dib-Hajj SD; Cummins TR
J Physiol; 2007 Jun; 581(Pt 3):1019-31. PubMed ID: 17430993
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Gating Properties and Use-Dependent Block of Nav1.5 and Nav1.7 Channels by Anti-Arrhythmics Mexiletine and Lidocaine.
Wang Y; Mi J; Lu K; Lu Y; Wang K
PLoS One; 2015; 10(6):e0128653. PubMed ID: 26068619
[TBL] [Abstract][Full Text] [Related]
17. Potent Inactivation-Dependent Inhibition of Adult and Neonatal NaV1.5 Channels by Lidocaine and Levobupivacaine.
Elajnaf T; Baptista-Hon DT; Hales TG
Anesth Analg; 2018 Sep; 127(3):650-660. PubMed ID: 29958221
[TBL] [Abstract][Full Text] [Related]
18. Isoform-selective effects of isoflurane on voltage-gated Na+ channels.
OuYang W; Hemmings HC
Anesthesiology; 2007 Jul; 107(1):91-8. PubMed ID: 17585220
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology of the Na
Osteen JD; Sampson K; Iyer V; Julius D; Bosmans F
Proc Natl Acad Sci U S A; 2017 Jun; 114(26):6836-6841. PubMed ID: 28607094
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of neuronal Na
Peng YS; Wu HT; Lai YC; Chen JL; Yang YC; Kuo CC
Neuropharmacology; 2020 Nov; 179():108266. PubMed ID: 32853658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
